Avectas partners with Vycellix to speed cell therapy production
The partners will combine expertise to progress the novel RNA immunomodulator, VY-M.
Archives for March 31, 2020
First US patient receives plasma therapy for coronavirus
FDA grants approval for the use of donated plasma from a recovered COVID-19 patient to be infused into a critically ill patient.